The European Commission Global Health Policy Forum

The European Commission organises the Global Health Policy Forum four times a year to meet and exchange information with representatives from different institutions, including international bodies such as the WHO, civil society organisations, private sector companies and academic institutions. The forum also serves the function of informing representatives from these institutions about the work of the European Commission and ongoing efforts that relate to different aspects of global health. Each forum is dedicated to a specific issue. The European Commission invites several speakers, who give a presentation and share their expertise and perspectives on the issue. The presentations are followed by an open discussion that involves the speakers as well as the forum's other participants. Past forums focused on issues such as health and migration, access to medicines and global health research.

Through the Global Health Policy Forum the European Commission hopes to ensure an open dialogue between Commission services and key stakeholders. In order to encourage openness and the sharing of information, discussion at the Global Health Policy Forum is held under Chatham House Rules, which specify that participants are free to use the information received, but cannot reveal the identity or affiliation of any of the speakers, nor that of any other participants.

 

A brief history of the Global Health Policy Forum

The Global Health Policy Forum was established following the Commission Communication on Global Health, adopted on 30 March 2010 and the subsequent Council conclusions, which were adopted in May 2010. The leading Commission services involved are DG Health and Food Safety, DG International Cooperation and Development, as well as DG Research and Innovation. The first Global Health Policy Forum was organized by DG Health and Food Safety in 2011. Since then each of the leading Commission services has been in charge of organising and chairing several meetings of the Global Health Policy Forum.

Information on all previous meetings of the Global Health Policy Forum

 

Events

12 December 2016
Global Health Policy Forum on Access to New Medicines

Agenda  | Participants List 

Presentations

• Ensuring Access Through Legal Provisions  826 KB
  Joan Herbert
  Director of Business Development, Medicines for Malaria Venture (MMV)
• Ensuring access to new medicines: A case study from TB Alliance  673 KB
  Willo Brock
  Senior Vice-President of External Affairs, Global Alliance for TB Drug Development (TB Alliance)
• Access without Excess: Bedaquiline  1.7 MB
  Myriam Theeuwes
  Compound Development Team Leader, J&J Janssen
• Global Antibiotic R&D Partnership (GARDP) - A Joint DNDi / WHO initiative  901 KB
  Jean-Pierre Paccaud
  Director of Business Development, Drugs for Neglected Diseases Initiative (DNDi)
• Enshrining Access in R&D: The 3P Project  409 KB
  Grania Brigden
  3P Project Lead, The International Union Against Tuberculosis and Lung Disease (The Union)

Further information

• Access case study from TB Alliance  90 KB
• Access case studies from DNDi  172 KB
• 3P Project – Fact sheet  553 KB

 

7 July 2016
Global Health Policy Forum on Health and Environment

Agenda  92 KB

Presentations

• Linking Environment and Health through the 2030 Development Agenda  5.9 MB
  Bettina Menne
  Coordinator of SDGs, WHO Regional Office Europe
• Our Planet, Our Health  1.6 MB
  Stuart Pritchard
  EU Affairs Manager, Wellcome Trust
• Activities and Plans for a Joint UNDP/WHO Programme on NCD Governance  2.7 MB
  Nick Banatvala
  Senior Adviser to the Assistant Director General, Noncommunicable Diseases and Mental Health, WHO
• Cancer Research UK’s International Tobacco Control Programme  194 KB
  Alastair Bradstock
  Programme Director, International Tobacco Control, Cancer Research UK
• European Regulatory Science on Tobacco- Policy Implementation to Reduce Lung Disease  1.1 MB
  Constantine Vardavas
  Programme Coordinator, European Network for Smoking and Tobacco Prevention (ENSP)

Info Points

• Research Fairness Conference, Brussels – 28 September 2016
• EDCTP2 Public Consultation

 

26 April 2016
Global Health Policy Forum on Access to Essential Medicines

Agenda  96 KB

Presentations

• Progress Update from the UN High Level Panel on Access to Medicines  787 KB
  Mandeep Dhaliwal
  Director: HIV, Health & Development Group, UNDP
• Access to Essential Medicines – A WHO Update  2.9 MB
  Stephane Vandam
  WHO, Public Health Officer
• Pharmaceutical Procurement & Supply Management in Under-Resourced Settings  690 KB
  Marianne Schürmann
  Hera Consultants, Partner
• Current Challenges and Opportunities for Access to Affordable Medicines  1.0 MB
  Rohit Malpani
  MSF, Director of Policy and Analysis
• Factsheet from Novartis Access in Kenya  479 KB
  Anthony Gitau
  Novartis, Head of Novartis Access in Kenya
• GSKs graduated approach to intellectual property in the developing world  482 KB
  Jon Pender
  GSK, Vice-President of Government Affairs
• Catalyzing Research Into Neglected Tropical Diseases  1.9 MB
  Tom Bombelles
  World Intellectual Property Organization, Head of Global Health
• Promoting innovation and access through voluntary licensing  6.8 MB
  Esteban Burrone
  Medicines Patent Pool, Head of Policy

 

25 February 2016
Global Health Policy Forum on Health and Migration

Agenda 99 KB

Presentations

• Migrants crisis: the urgent need for adequate and integrated public health services at reception
  Francois Fille
  European Advocacy Coordinator, Medecins du Monde (MdM), Belgium
• EU Trust Fund on migration
  Anne Nicolay
  European Commission - International Cooperation and Development
• From Brain Drain to Brain Gain
  Danila Chiaro
  European Commission - International Cooperation and Development
• UNFPA's State of the World Population Report 2015
  Ivan Hermans
  Senior Policy and External Relations Advisor, UNFPA, Belgium
• Humanitarian Health Best Practice - Applied to Provision of Medical Services to Refugees & Migrants
  Matthew Sayer
  European Commission - International Cooperation and Development